| Dilutive Effect on Earnings Per Share |
The following tables illustrate the dilutive effect of such items on earnings per share for the three and nine months ended September 30, 2017 and 2016:
|
|
|
Three Months Ended September 30, 2017
|
|
|
|
|
|
|
|
|
Income (Loss)
|
|
|
Income (Loss)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
From Continuing
|
|
|
From Discontinued
|
|
|
Net
|
|
|
|
|
|
|
|
|
Operations
|
|
|
Operations
|
|
|
Income (Loss)
|
|
|
|
|
Weighted
|
|
|
|
|
|
|
Per
|
|
|
|
|
|
|
Per
|
|
|
|
|
|
|
Per
|
|
|
|
|
Average
|
|
|
|
|
|
|
Share
|
|
|
|
|
|
|
Share
|
|
|
|
|
|
|
Share
|
|
|
|
|
Shares
|
|
|
Amount
|
|
|
Amount
|
|
|
Amount
|
|
|
Amount
|
|
|
Amount
|
|
|
Amount
|
|
|
|
|
(In thousands, except per share amounts)
|
|
|
Earnings (loss) and shares
|
|
|
43,496
|
|
|
$
|
19,730
|
|
|
|
|
|
|
$
|
(290
|
)
|
|
|
|
|
|
$
|
19,440
|
|
|
|
|
|
|
Effect of participating securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-vested restricted stock
|
|
|
|
|
|
|
(18
|
)
|
|
|
|
|
|
|
-
|
|
|
|
|
|
|
|
(18
|
)
|
|
|
|
|
|
Basic earnings (loss) and shares
|
|
|
43,496
|
|
|
$
|
19,712
|
|
|
$
|
0.45
|
|
|
$
|
(290
|
)
|
|
$
|
-
|
|
|
$
|
19,422
|
|
|
$
|
0.45
|
|
|
Effect of dilutive securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock compensation plans
|
|
|
315
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted earnings (loss) and shares
|
|
|
43,811
|
|
|
$
|
19,712
|
|
|
$
|
0.45
|
|
|
$
|
(290
|
)
|
|
$
|
(0.01
|
)
|
|
$
|
19,422
|
|
|
$
|
0.44
|
|
|
|
|
Three Months Ended September 30, 2016
|
|
|
|
|
|
|
|
|
Income (Loss)
|
|
|
Income (Loss)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
From Continuing
|
|
|
From Discontinued
|
|
|
Net
|
|
|
|
|
|
|
|
|
Operations
|
|
|
Operations
|
|
|
Income (Loss)
|
|
|
|
|
Weighted
|
|
|
|
|
|
|
Per
|
|
|
|
|
|
|
Per
|
|
|
|
|
|
|
Per
|
|
|
|
|
Average
|
|
|
|
|
|
|
Share
|
|
|
|
|
|
|
Share
|
|
|
|
|
|
|
Share
|
|
|
|
|
Shares
|
|
|
Amount
|
|
|
Amount
|
|
|
Amount
|
|
|
Amount
|
|
|
Amount
|
|
|
Amount
|
|
|
|
|
(In thousands, except per share amounts)
|
|
|
Earnings (loss) and shares
|
|
|
45,118
|
|
|
$
|
18,969
|
|
|
|
|
|
|
$
|
(858
|
)
|
|
|
|
|
|
$
|
18,111
|
|
|
|
|
|
|
Effect of participating securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-vested restricted stock
|
|
|
|
|
|
|
(11
|
)
|
|
|
|
|
|
|
-
|
|
|
|
|
|
|
|
(11
|
)
|
|
|
|
|
|
Basic earnings (loss) and shares
|
|
|
45,118
|
|
|
$
|
18,958
|
|
|
$
|
0.42
|
|
|
$
|
(858
|
)
|
|
$
|
(0.02
|
)
|
|
$
|
18,100
|
|
|
$
|
0.40
|
|
|
Effect of dilutive securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock compensation plans
|
|
|
236
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted earnings (loss) and shares
|
|
|
45,354
|
|
|
$
|
18,958
|
|
|
$
|
0.42
|
|
|
$
|
(858
|
)
|
|
$
|
(0.02
|
)
|
|
$
|
18,100
|
|
|
$
|
0.40
|
|
|
|
|
Nine Months Ended September 30, 2017
|
|
|
|
|
|
|
|
|
Income (Loss)
|
|
|
Income (Loss)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
From Continuing
|
|
|
From Discontinued
|
|
|
Net
|
|
|
|
|
|
|
|
|
Operations
|
|
|
Operations
|
|
|
Income (Loss)
|
|
|
|
|
Weighted
|
|
|
|
|
|
|
Per
|
|
|
|
|
|
|
Per
|
|
|
|
|
|
|
Per
|
|
|
|
|
Average
|
|
|
|
|
|
|
Share
|
|
|
|
|
|
|
Share
|
|
|
|
|
|
|
Share
|
|
|
|
|
Shares
|
|
|
Amount
|
|
|
Amount
|
|
|
Amount
|
|
|
Amount
|
|
|
Amount
|
|
|
Amount
|
|
|
|
|
(In thousands, except per share amounts)
|
|
|
Earnings (loss) and shares
|
|
|
44,281
|
|
|
$
|
32,024
|
|
|
|
|
|
|
$
|
(993
|
)
|
|
|
|
|
|
$
|
31,031
|
|
|
|
|
|
|
Effect of participating securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-vested restricted stock
|
|
|
|
|
|
|
(28
|
)
|
|
|
|
|
|
|
-
|
|
|
|
|
|
|
|
(28
|
)
|
|
|
|
|
|
Basic earnings (loss) and shares
|
|
|
44,281
|
|
|
$
|
31,996
|
|
|
$
|
0.72
|
|
|
$
|
(993
|
)
|
|
$
|
(0.02
|
)
|
|
$
|
31,003
|
|
|
$
|
0.70
|
|
|
Effect of dilutive securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock compensation plans
|
|
|
304
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted earnings (loss) and shares
|
|
|
44,585
|
|
|
$
|
31,996
|
|
|
$
|
0.72
|
|
|
$
|
(993
|
)
|
|
$
|
(0.02
|
)
|
|
$
|
31,003
|
|
|
$
|
0.70
|
|
|
|
|
Nine Months Ended September 30, 2016
|
|
|
|
|
|
|
|
|
Income (Loss)
|
|
|
Income (Loss)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
From Continuing
|
|
|
From Discontinued
|
|
|
Net
|
|
|
|
|
|
|
|
|
Operations
|
|
|
Operations
|
|
|
Income (Loss)
|
|
|
|
|
Weighted
|
|
|
|
|
|
|
Per
|
|
|
|
|
|
|
Per
|
|
|
|
|
|
|
Per
|
|
|
|
|
Average
|
|
|
|
|
|
|
Share
|
|
|
|
|
|
|
Share
|
|
|
|
|
|
|
Share
|
|
|
|
|
Shares
|
|
|
Amount
|
|
|
Amount
|
|
|
Amount
|
|
|
Amount
|
|
|
Amount
|
|
|
Amount
|
|
|
|
|
(In thousands, except per share amounts)
|
|
|
Earnings (loss) and shares
|
|
|
45,930
|
|
|
$
|
56,475
|
|
|
|
|
|
|
$
|
(918
|
)
|
|
|
|
|
|
$
|
55,557
|
|
|
|
|
|
|
Effect of participating securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-vested restricted stock
|
|
|
|
|
|
|
(31
|
)
|
|
|
|
|
|
|
-
|
|
|
|
|
|
|
|
(31
|
)
|
|
|
|
|
|
Basic earnings (loss) and shares
|
|
|
45,930
|
|
|
$
|
56,444
|
|
|
$
|
1.23
|
|
|
$
|
(918
|
)
|
|
$
|
(0.02
|
)
|
|
$
|
55,526
|
|
|
$
|
1.21
|
|
|
Effect of dilutive securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock compensation plans
|
|
|
200
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted earnings (loss) and shares
|
|
|
46,130
|
|
|
$
|
56,444
|
|
|
$
|
1.22
|
|
|
$
|
(918
|
)
|
|
$
|
(0.02
|
)
|
|
$
|
55,526
|
|
|
$
|
1.20
|
|
|